Since the specific therapy for the group of diseases that require splenectomy is often in a state of flux and since some of the conditions are complicated by problems of coagulation, it is important that the indications and timing for surgery be worked out in close cooperation with an experienced hematologist. Splenectomy may be indicated for patients with hereditary anemias (spherocytosis, elliptocytosis, nonspherocytic hemolytic anemia), primary hypersplenism, and chronic idiopathic thrombocytopenic purpura. Patients with autoimmune hemolytic anemia, secondary hypersplenism, thalassemia, myelofibrosis, chronic lymphatic leukemia, and lymphoma also may benefit from splenectomy in selected situations. Until recently splenectomy was a routine part of the staging procedure for patients with Hodgkin’s disease, but this is no longer accepted.
KeywordsCatheter Lymphoma Leukemia Aspirin Heparin
Unable to display preview. Download preview PDF.